Clinical Trials Logo

Neural Tube Defects clinical trials

View clinical trials related to Neural Tube Defects.

Filter by:

NCT ID: NCT06197399 Not yet recruiting - Clinical trials for Recurrent Adult Tethered Cord Syndrome

A Randomized Controlled Trial for Surgical Treatment of Recurrent Adult Tethered Cord Syndrome

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

This trial compares detethering surgery and spinal column shortening surgery, two treatments for adults with recurrent tethered cord syndrome (TCS), a neurological disorder where the spinal cord becomes abnormally attached to tissue. Detethering surgery carries a higher risk of postoperative complications such as cerebrospinal fluid (CSF) leakage, while spinal column shortening surgery's comparative efficacy is unclear. This study aims to clarify the optimal surgical management for recurrent TCS in adults, assessing postoperative complication rate and improvement of symptoms.

NCT ID: NCT06174883 Completed - Spina Bifida Clinical Trials

Salt-FA to Increase Folate Levels

Start date: June 1, 2022
Phase:
Study type: Observational

Question: How effective is folic acid-fortified iodized salt in increasing serum folate concentrations among non-pregnant and non-lactating women of reproductive age? Hypothesis: Folic acid-fortified iodized salt can increase serum folate levels and serve as a policy consideration in salt fortification with both iodine and folic acid to reduce serious and fatal birth defects.

NCT ID: NCT06135883 Completed - Neural Tube Defects Clinical Trials

Assessing Folic Acid in High-Risk Pregnancy for Neural Tube Defects

Start date: February 20, 2023
Phase:
Study type: Observational [Patient Registry]

Aim of this study is to investigate and statistically reveal the prevalence and awareness of folic acid usage in pregnant women who have at least one of the risk factors for neural tube defects, to express the level of knowledge of the determined population on this subject and to present ideas to increase awareness in the society.

NCT ID: NCT05962086 Recruiting - Spinal Dysraphism Clinical Trials

Determining Developmental and Clinical Markers Affecting Urinary Function of Children With Spinal Dysraphism

Start date: October 22, 2022
Phase:
Study type: Observational

To identify developmental and clinical biomarkers that affect urinary incontinence at the ages of 5, 7, and 10 according to different neuro-urological clinical factors.

NCT ID: NCT05935631 Completed - Neural Tube Defects Clinical Trials

Feasibility, Acceptability and Directional Signal Effect on Blood Folate Levels of Iodized Salt Fortified With Folic Acid: Clinical Study

FASALT
Start date: January 24, 2023
Phase: N/A
Study type: Interventional

Aim 1: Assess directional signal of effect of fortified salt with folic acid and iodine on blood serum folate levels. It will be accomplished by feasibility pre-test/post-test clinical study by estimating mean and variability of serum blood folate levels effects of folic acid fortified salt. Hypothesis: Fortified salt with folic acid and iodine will increase serum blood folate levels from baseline by month 1. Aim 2: Assess feasibility and acceptability of salt fortified with folic acid and iodine. Feasibility will be measured by 1) subjects' refusal rate of consent by 30 subjects during 6-month enrollment period; 2) method of determining salt consumption (weighting the saltshaker pre and post); 3) completion rates of study protocols from baseline to follow up. Hypothesis 1a: Completion of all blood draw visits will be 90-100%. Acceptability will be measured by 1) completion rate of daily salt logs; 2) consumption of salt by weighting saltshakers; 3) attitude towards taste and color difference. Hypothesis 1b: Completion rate (90-100%) of daily salt logs will range from 90-100% of participants and 2) consumption of salt will range from 90-100% of participants. Dietary surveys will be employed to document dietary habits and estimated daily FA intake in the sample population. Feasibility and acceptability of dietary surveys will be measured by willingness to answer survey questions. Hypothesis 1c: Completion rate of dietary surveys will range 90-100%.

NCT ID: NCT05883761 Completed - Clinical trials for Congenital Abnormalities

Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment

Start date: September 7, 2021
Phase:
Study type: Observational

The goal of this observational study is to assess the birth outcomes of HIV-positive women delivering in hospitals in Eswatini who are receiving dolutegravir (DTG) or other anti-retroviral (ARV) drug regimens. The main question the study aims to answer is, what is the proportion of neural tube defects among live and stillborn infants delivered by: - HIV-positive women on DTG at conception - HIV-negative women - HIV-positive women on non-DTG ARV at conception Participants will be interviewed for information on HIV testing and antiretroviral therapy history, other medical history of selected conditions (e.g., diabetes, malaria, TB) and potential birth defect exposures. Photographs will be taken of the infants. Data on mothers' pregnancy history, birth outcomes, and HIV and ARV information (as applicable) will be collected from patient records.

NCT ID: NCT05718440 Recruiting - Spinal Dysraphism Clinical Trials

Uronephrological Complications Risk Factors in Spinal Dysraphism

RUD
Start date: November 6, 2023
Phase:
Study type: Observational

Spinal dysraphism consist of congenital malformations resulting of abnormalities in the formation of neural tube and/or surrounding structures during embryogenesis. The aim of this study is to assess if there are specific clinical and paraclinical patterns of pelvic (urinary, bowel, sexual) disorders depending on the dysraphism's type and level of injury. This description will help to determine a prognosis on symptoms and the risk of complication depending on the dysraphism's type and level of injury. It will provide targeted evaluation and cares: identifying patients who will be at risk of complications and needing acute monitoring or preventing cares on the symptoms' onset. Pelvic disorders have an important impact on morbi-mortality (urinary dysfunction is the first cause of mortality in adults by renal failure or infection) and also on patients' quality of life.

NCT ID: NCT05672849 Recruiting - Neural Tube Defects Clinical Trials

Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases

Start date: November 14, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the safety and efficacy of devices used in patients undergoing fetoscopic neural tube defect repair.

NCT ID: NCT05579795 Not yet recruiting - Clinical trials for Tethered Cord Syndrome

Surgical Management and Outcome of Tethered Cord Syndrome

Start date: November 2, 2022
Phase:
Study type: Observational

The aim of this study is to assess surgical management and outcome of Tethered cord syndrome

NCT ID: NCT05454085 Completed - Neural Tube Defects Clinical Trials

Could Bisphenol-A Have a Role in the Etiology of Neural Tube Defects

Start date: April 15, 2021
Phase: N/A
Study type: Interventional

Our aim in this study is in patients with a diagnosis of neural tube defect; is the measurement of BPA levels in maternal blood and amniotic fluid.